Q3 2018 Holdings
Filed 2018-11-14 | 47 holdings | $98.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $47.9M | 1,300,000 | 48.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $30.0M | 1,750,000 | 30.6% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $10.0M | 130,000 | 10.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.0M | 195,000 | 4.1% |
| Cellectis SA(CLLS) | SPONSORED ADS | 15117K103 | $3.1M | 110,000 | 3.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.8M | 650,000 | 2.9% |
| Loxo Oncology | COM | 548862101 | $29.9K | 175,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $26.0K | 1,600,000 | 0.0% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $23.4K | 300,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $16.3K | 420,000 | 0.0% |
| Polarityte Inc | COM | 731094108 | $14.6K | 765,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $14.4K | 825,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $12.2K | 200,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $8.9K | 225,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $8.7K | 725,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $8.5K | 180,000 | 0.0% |
| Amag Pharmaceuticals Inc(AMAG) | COM | 00163U106 | $8.4K | 420,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $8.4K | 1,730,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $8.3K | 490,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $8.0K | 975,000 | 0.0% |
| Miragen Therapeutics Inc | COM | 60463E103 | $7.8K | 1,395,700 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $7.7K | 698,100 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.0K | 465,200 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.7K | 375,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $6.1K | 180,000 | 0.0% |
| Ultragenyx Pharmaceuticals Inc(RARE) | COM | 90400D108 | $6.1K | 80,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.6K | 320,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.5K | 800,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $5.3K | 1,200,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $5.2K | 550,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $4.6K | 1,185,000 | 0.0% |
| Imprimis Pharmaceuticals | COM NEW | 45323A201 | $4.5K | 1,620,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.7K | 325,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $3.3K | 1,550,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $3.1K | 550,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $3.1K | 130,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $2.1K | 200,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.0K | 350,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $1.8K | 2,500,000 | 0.0% |
| Clementia Pharmaceutical Inc | COM | 185575107 | $1.7K | 148,832 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $1.6K | 51,000 | 0.0% |
| Biofrontera AG | SPONSORED ADR | 09075G105 | $1.1K | 79,007 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $1.1K | 97,400 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $1.0K | 275,000 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $745 | 275,000 | 0.0% |
| Foamix LTD | SHS | M46135105 | $521 | 91,000 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $267 | 250,000 | 0.0% |